{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:17:40Z","timestamp":1788419860873,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tiv.2025.106023","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:02:32Z","timestamp":1739311352000},"page":"106023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessing the safety of midazolam: A comprehensive analysis of adverse events from FAERS"],"prefix":"10.1016","volume":"105","author":[{"given":"Jieyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songsong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tiv.2025.106023_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100594","article-title":"Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: a real-world analysis of the Food and Drug Administration (FDA) adverse event reporting system (FAERS)","volume":"14","author":"Bian","year":"2021","journal-title":"World Allergy Organ. J."},{"issue":"7","key":"10.1016\/j.tiv.2025.106023_bb0010","first-page":"658","article-title":"An unusual case of delayed midazolam anaphylaxis and a review of the current literature","volume":"28","author":"Cochran-Caggiano","year":"2023","journal-title":"J. Pediatr. Pharmacol. Therap."},{"issue":"5","key":"10.1016\/j.tiv.2025.106023_bb0015","article-title":"Midazolam for sedation before procedures","volume":"2016","author":"Conway","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.tiv.2025.106023_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","article-title":"New benzodiazepines for sedation","volume":"32","author":"Cornett","year":"2018","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"issue":"1","key":"10.1016\/j.tiv.2025.106023_bb0025","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/s41598-023-50013-7","article-title":"Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database","volume":"14","author":"Eshwar","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2025.106023_bb0030","author":"FDA1"},{"key":"10.1016\/j.tiv.2025.106023_bb0035","author":"FDA2"},{"key":"10.1016\/j.tiv.2025.106023_bb0040","author":"FDA3"},{"key":"10.1016\/j.tiv.2025.106023_bb0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.bdj.4811574","article-title":"Practical conscious sedation","volume":"197","author":"Girdler","year":"2004","journal-title":"Br. Dent. J."},{"issue":"1","key":"10.1016\/j.tiv.2025.106023_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23726-4","article-title":"A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib","volume":"12","author":"Guo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2025.106023_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1339721","article-title":"A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam","volume":"15","author":"He","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.tiv.2025.106023_bb0060","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1111\/epi.17916","article-title":"Effects of midazolam on high-frequency oscillations in amygdala and hippocampus of epilepsy patients","volume":"65","author":"Hebel","year":"2024","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.tiv.2025.106023_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.anai.2017.07.013","article-title":"Evaluation of periprocedural hypersensitivity reactions","volume":"119","author":"Iammatteo","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.tiv.2025.106023_bb0070","author":"International Narcotics Control Board"},{"issue":"1","key":"10.1016\/j.tiv.2025.106023_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17245\/jdapm.2020.20.1.1","article-title":"Midazolam use in pediatric dentistry: a review","volume":"20","author":"Jain","year":"2020","journal-title":"J. Dent. Anesth. Pain Med."},{"issue":"41","key":"10.1016\/j.tiv.2025.106023_bb0080","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017405","article-title":"Midazolam anaphylaxis during general anesthesia: a case report","volume":"98","author":"Jeon","year":"2019","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.tiv.2025.106023_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/PTS.0b013e3181a5dafa","article-title":"Midazolam-related drug interactions: detection of risk situations to the patient safety in a brazilian teaching hospital","volume":"5","author":"Kawano","year":"2009","journal-title":"J. Patient Saf."},{"issue":"4","key":"10.1016\/j.tiv.2025.106023_bb0090","first-page":"237","article-title":"Midazolam: a review of its use for conscious sedation of children","volume":"15","author":"Kupietzky","year":"1993","journal-title":"Pediatr. Dent."},{"key":"10.1016\/j.tiv.2025.106023_bb0095","series-title":"Contemporary Practice in Clinical Chemistry (Fourth Edition)","author":"Loralie","year":"2020"},{"issue":"2","key":"10.1016\/j.tiv.2025.106023_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.tiv.2025.106023_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.15586\/aei.v49i4.238","article-title":"Allergic reactions to midazolam: a case series from an Italian allergy unit","volume":"49","author":"Nucera","year":"2021","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.tiv.2025.106023_bb0110","series-title":"Modern Anesthetics. Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-74806-9_16","article-title":"Midazolam and other benzodiazepines","volume":"vol. 182","author":"Olkkola","year":"2008"},{"issue":"6","key":"10.1016\/j.tiv.2025.106023_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100315","article-title":"Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA adverse event reporting system (FAERS)","volume":"6","author":"Omar","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.tiv.2025.106023_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.764279","article-title":"Neuropsychiatric adverse events of Montelukast: an analysis of real-world datasets and drug-gene interaction network","volume":"12","author":"Umetsu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.tiv.2025.106023_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40708-020-00116-y","article-title":"Neuropsychopharmacological effects of midazolam on the human brain","volume":"7","author":"Wang","year":"2020","journal-title":"Brain Inform."},{"key":"10.1016\/j.tiv.2025.106023_bb0130","article-title":"Delayed anaphylactic reaction to midazolam in the absence of immediate respiratory or skin manifestations","volume":"2023","author":"Winegarner","year":"2023","journal-title":"Case Rep. Anesthesiol."},{"issue":"18","key":"10.1016\/j.tiv.2025.106023_bb0135","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/ajhp\/59.18.1742","article-title":"Identifying clinically significant preventable adverse drug events through a hospital\u2019s database of adverse drug reaction reports","volume":"59","author":"Winterstein","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"3","key":"10.1016\/j.tiv.2025.106023_bb0140","first-page":"422","article-title":"Signal mining and analysis for central nervous system adverse events due to taking oxycodone based on FAERS database","volume":"48","author":"Wu","year":"2023","journal-title":"J. Central South Univ. Med. Sci."}],"updated-by":[{"DOI":"10.1016\/j.tiv.2025.106103","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:23:47Z","timestamp":1741591427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233325000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"alternative-id":["S0887233325000177"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106023","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the safety of midazolam: A comprehensive analysis of adverse events from FAERS","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106023"}}